Liquid Biopsies can provide additional patient data less invasively than standard tissue biopsies. The integration of liquid biopsies into clinical practice will enable a greater understanding of the patient through faster disease detection, earlier diagnosis, enhanced disease monitoring and treatment response and therefore delivering enhanced personalized healthcare.

This conference offers the biopharmaceutical industry the opportunity to examine the latest developments in the field with dedicated congress presentations, panel discussions and roundtables that study novel methods, research techniques, advances and discoveries in the field, through research applications utilizing technologies such as qPCR, Digital PCR and NGS.

With presentations on circulating biomarkers such as cell-free DNA, (cfDNA), circulation tumor cells (CTCs), and extracellular vesicles (EVs) this meeting will allow you to keep up to date with the cutting edge of research and the opportunity to further knowledge and business partnerships with those in your field.